Adi Turjeman
Impact in
-
- Antibiotic Use and Resistance
- Molecular Medicine top 5%
- Antibiotic Resistance in Bacteria
Papers in
-
- Urinary Tract Infections Management 6
-
- Diabetes Treatment and Management 4
- Co-authors
- Leonard Leibovici (15 shared papers)Dafna Yahav (8 shared papers)Elodie von Dach (5 shared papers)Angela Huttner (5 shared papers)Noa Eliakim‐Raz (6 shared papers)Tanya Babich (5 shared papers)Mical Paul (7 shared papers)Begoña Martínez de Tejada (2 shared papers)
- Journals
- The Journal of Clinical Endocrinology & Metabolism (2 papers)Spine (1 paper)Diabetes & Metabolism (1 paper)BMJ Open (1 paper)Gerontology (1 paper)
- Partner nations
- IsraelSwitzerlandItaly
In The Last Decade
Adi Turjeman
25 papers receiving 297 citations
Peers
Comparison fields: 5 of 75
- Applied Microbiology and Biotechnology 40
- Molecular Medicine 76
- Urology 45
- Clinical Biochemistry 44
- Epidemiology 152
Countries citing papers authored by Adi Turjeman
This map shows the geographic impact of Adi Turjeman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adi Turjeman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adi Turjeman more than expected).
Fields of papers citing papers by Adi Turjeman
This network shows the impact of papers produced by Adi Turjeman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adi Turjeman. The network helps show where Adi Turjeman may publish in the future.
Co-authors
The 25 scholars most cited alongside Adi Turjeman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 26 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 125 | |
| 2 | 2022 | 48 | |
| 3 | 2022 | 27 | |
| 4 | 2021 | 17 | |
| 5 | 2024 | 13 | |
| 6 | 2022 | 9 | |
| 7 | 2018 | 7 | |
| 8 | 2021 | 7 | |
| 9 | 2022 | 7 | |
| 10 | 2021 | 6 | |
| 11 | 2021 | 6 | |
| 12 | 2023 | 5 | |
| 13 | 2023 | 5 | |
| 14 | 2024 | 3 | |
| 15 | 2022 | 3 | |
| 16 | 2023 | 3 | |
| 17 | 2025 | 2 | |
| 18 | 2025 | 2 | |
| 19 | 2021 | 1 | |
| 20 | 2022 | 1 |
About Adi Turjeman
Adi Turjeman is a scholar working on Epidemiology, Endocrinology, Diabetes and Metabolism, Infectious Diseases, Clinical Biochemistry and Applied Microbiology and Biotechnology, having authored 26 papers that have together received 302 indexed citations. Recurring topics across this work include Urinary Tract Infections Management (6 papers), Bacterial Identification and Susceptibility Testing (5 papers), Antibiotic Use and Resistance (5 papers), Diabetes Treatment and Management (4 papers), SARS-CoV-2 and COVID-19 Research (4 papers), Pelvic floor disorders treatments (3 papers), Long-Term Effects of COVID-19 (3 papers) and Urinary Bladder and Prostate Research (3 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (40 citations), Molecular Medicine (76 citations), Urology (45 citations), Clinical Biochemistry (44 citations) and Epidemiology (152 citations) Adi Turjeman has collaborated with scholars based in Israel, Switzerland and Italy. Frequent co-authors include Leonard Leibovici, Dafna Yahav, Elodie von Dach, Angela Huttner, Noa Eliakim‐Raz, Tanya Babich, Mical Paul, Begoña Martínez de Tejada, Shachaf Shiber and Caroline Brossier. Their work appears in journals such as The Journal of Clinical Endocrinology & Metabolism, Spine, Diabetes & Metabolism, BMJ Open and Gerontology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.